Balanced news tone
News Sentiment
AZTA sentiment intelligence
Azenta Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
-1.9% over one week, +12.3% over four weeks, trend inactive, and below fair value.
Why is Azenta (AZTA) Trading So Low Despite Strong Balance Sheet
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
Pomerantz LLP is investigating potential securities fraud claims against Azenta, Inc. (AZTA) on behalf of investors. This investigation follows Azenta's Q2 fiscal 2026 results, which fell short of expectations, revealing "execution gaps" and a "more cautious demand environment,"
- Tone
- Negative 29/100
- Event
- Regulatory and legal
- Published
- 04 Jun 2026 13:40
- Source
- PR Newswire
How Azenta Inc. (AZTA) Affects Rotational Strategy Timing
This article analyzes Azenta Inc. (AZTA) using AI models to provide trading strategies and a multi-timeframe signal analysis. It highlights strong near and mid-term sentiment but a weak long-term outlook for AZTA, presenting specific entry, target, and stop-loss zones for positio
- Tone
- Positive 72/100
- Event
- Guidance
- Published
- 02 Jun 2026 20:50
- Source
- Stock Traders Daily
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 20:05
- Source
- PR Newswire
Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- Market source
INVESTOR ALERT: Pomerantz Law Firm Investigates ClaimsOn Behalf of Investors of Azenta, Inc. - AZTA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 May 2026 07:00
- Source
- PR Newswire
Earnings call transcript: Azenta Q2 2026 results disappoint, stock tumbles
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 07:00
- Source
- Investing.com
Azenta, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Azenta, Inc. (AZTA)
- Tone
- Negative 34/100
- Event
- Regulatory and legal
- Published
- 13 May 2026 07:00
- Source
- Morningstar
Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 May 2026 07:00
- Source
- StockStory
Azenta, Inc. Q2 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
Azenta Q2 Earnings Call Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Market source
Azenta Q2 2026 slides: revenue miss, $149M impairment trigger 22% drop
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- Investing.com
Azenta (AZTA) Quarterly Loss Of US$157 Million Reinforces Bearish Margin Narratives
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 06 May 2026 07:00
- Source
- simplywall.st
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- PR Newswire
Azenta Q2 2026 Earnings Preview — Street Expects $0.14 EPS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- AlphaStreet
How The Azenta (AZTA) Investment Narrative Is Shifting As Analysts Recut Valuation Targets
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 May 2026 07:00
- Source
- Market source
Assessing Azenta (AZTA) Valuation After Recent Share Price Volatility
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- Market source
Azenta (AZTA) Fell on Operational Challenges and Uneven Execution
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Apr 2026 07:00
- Source
- Market source
Assessing Azenta (AZTA) Valuation After A Short-Term Rebound And Longer-Term Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Mar 2026 07:00
- Source
- Market source
Has Azenta (AZTA) Fallen Too Far After Recent Share Price Weakness?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Mar 2026 07:00
- Source
- Market source
Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Feb 2026 08:00
- Source
- Market source
Does Azenta (AZTA) Earnings, Buyback Pause, and Board Change Hint at a Strategic Crossroads?
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 Feb 2026 08:00
- Source
- Market source
Azenta (AZTA) Stock Trades Down, Here Is Why
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- Market source